GET THE APP

Journal of Blood & Lymph

Journal of Blood & Lymph

ISSN: 2165-7831

Open Access

Hirokazu Miki

Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan

Publications
  • Commentary   
    Hyperthermia against plasma cell dyscrasias
    Author(s): Hirokazu Miki*

    Multiple Myeloma (MM) remains incurable and thus, innovative therapeutic options are needed. MM cells not only reside in the bone marrow, but also expand outside bone. The extramedullary expansion of plasmacytoma is generally accepted to represent a high-risk condition with more aggressive features and a poorer prognosis. Therefore, novel therapeutic options with different modes of action against MM and extramedullary plasmacytoma need to be developed. Hyperthermia is an ancient and unique treatment option for cancers. We previously reported the anti-MM effects of hyperthermia combined with proteasome inhibitors. To apply the cytotoxic effect of hyperthermia, we developed novel superparamagnetic nanoparticles, which accumulate in extramedullary tumors in mouse plasmacytoma models and generate heat locally with alternative magnetic currency. This commentary provides detailed insights i.. Read More»
    DOI: 10.37421/2165-7831.2025.15.339

    Abstract HTML PDF

Google Scholar citation report
Citations: 443

Journal of Blood & Lymph received 443 citations as per Google Scholar report

Journal of Blood & Lymph peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward